| abstract |
The invention provides magnesium S-omeprazolato coordination compounds according to formula (I): [Mg(solva)x(solvb)y][Mg(S-omeprazolato)3]2•(solvc)z (I), pharmaceutical compositions and processes of making the same. In formula (I), solva, solvb, and solvc represent solvent molecules where x and y are independently selected from integers 0 to 6, the sum of which is 4 or 6, while z is a positive rational number from 0 to 6. The compounds are useful for the treatment of gastric acid related conditions and the inhibition of gastric acid secretion. |